Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
When To Choose Passive Funds discusses scenarios where passive investing aligns with goals, especially for long-term, low-cost portfolios.
12,361 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
A mid‑sized fund just boosted its stake in ServiceTitan after a sharp share drop. This article unpacks what the move ...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A Massachusetts case targets the forfeiture of $327K in Tether tied to an alleged dating-app crypto scam. Authorities...
When a large investor opens million position in an industrial REIT, it signals confidence in long-term cash flow and ...
KAST announces an $80 million Series A led by QED Investors and Left Lane Capital, valuing the stablecoin fintech at ...
A new look at how digital money, especially stablecoins, is shaping illegal gold markets. Learn why stablecoins have ...
A major hedge fund trimmed its ZoomInfo position by millions, fueling questions about the company's prospects. This a...
A high-profile export case links AI hardware, sanctions, and risk for investors. This article breaks down what happen...
Hedge-fund CIOs say the refining space offers persistent profit potential due to structural capacity limits, even as ...
A feud in late-night TV isn’t just talk. It can echo through stocks, regulator moves, and your budget. Learn how to s...
A major fund is doubling down on Lionsgate Studios as shares skyrocket. Learn what know about this bet, the strategy ...